How are energy investors positioned?
James H. Roth, a director at Huron Consulting Group Inc. (NASDAQ:HURN), executed a series of stock sales totaling $1.28 million on March 5, according to a recent SEC filing. The company, currently valued at $2.4 billion, has demonstrated strong momentum with a 39% return over the past six months and maintains a "GREAT" overall financial health score according to InvestingPro analysis. Roth sold 8,642 shares of the company’s common stock at prices ranging from $146.82 to $148.66 per share. These transactions were conducted under a pre-established Rule 10b5-1 trading plan. Following the sales, Roth retains direct ownership of 73,563 shares and indirect ownership of 3,855 shares through a family LLC. Based on InvestingPro’s Fair Value analysis, the stock appears fairly valued, trading near its calculated Fair Value. Notably, while insiders like Roth are selling, management has been actively buying back shares, and analysts project earnings growth with a favorable PEG ratio of 0.22.
In other recent news, Huron Consulting Group reported a strong financial performance for the fourth quarter of 2024, with earnings per share (EPS) of $1.90, surpassing analyst expectations of $1.52. The company’s revenue for the quarter reached $399.31 million, exceeding the anticipated $379.99 million. Analysts, including those from Benchmark and Truist Securities, responded positively to these results, with both firms raising their price targets for Huron to $165 while maintaining a Buy rating. Benchmark analyst Bill Sutherland highlighted the company’s strong fourth-quarter performance and promising 2025 guidance as reasons for the upgrade.
Truist Securities also increased its price target to $180, citing potential growth in Huron’s core markets, particularly in healthcare and higher education. The firm revised its adjusted EPS estimate for Huron upward to $8.28 for the year 2026, reflecting confidence in the company’s ability to capitalize on changing federal spending. Huron’s guidance for 2025 projects an EPS range of $6.80-$7.60, with revenue estimates between $1.58-1.66 billion. The company also reported a 9.1% increase in annual revenues for 2024, reaching a record $1.49 billion.
Additionally, Huron’s net income for 2024 saw a remarkable increase of 86.7% to $116.6 million, with diluted EPS nearly doubling to $6.27. The company returned $122.2 million to shareholders through share repurchases and reported a significant rise in net cash from operating activities. Huron’s strategic initiatives in healthcare and education, alongside its focus on margin expansion, are expected to continue driving growth in the coming years.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.